Kneeland Youngblood

Pharos Capital Group thesis

Pharos' mission is to achieve attractive risk-adjusted returns by being a value added partner with deep operating expertise in healthcare. We believe greater transparency in health care quality and cost, combined with immense cost pressures from payers, creates a unique market for companies that improve outcomes and lower the total cost of healthcare. Where possible, we also seek to serve underserved areas and populations, as well as small and complex populations, by improving availability and access to high quality care and cost effective healthcare solutions and services. The cornerstone of

Sector and stage focus

• Series B: Medical Devices, SaaS, Health IT
• general: Diverse Investors, Austin

Is Kneeland Youngblood a fit for your round?

Upload your pitch deck and see whether Kneeland Youngblood appears in your top 20 matches.